Anti-cancer virus desensitization method

Details for Australian Patent Application No. 2004266102 (hide)

Owner Wellstat Biologics Corporation

Inventors Lorence, Robert M.

Agent FB Rice

Pub. Number AU-B-2004266102

PCT Pub. Number WO2005/018580

Priority 60/457,035 24.03.03 US

Filing date 2 March 2004

Wipo publication date 3 March 2005

Acceptance publication date 29 May 2008

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 39/17 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

22 September 2005 PCT application entered the National Phase

  PCT publication WO2005/018580 Priority application(s): WO2005/018580

29 May 2008 Application Accepted

  Published as AU-B-2004266102

25 September 2008 Standard Patent Sealed

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266111-Compositions and methods for treatment of severe acute respiratory syndrome (SARS)

2004266100-Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters